Who is Will Klein? Meet the Dodgers reliever who played hero in that marathon World Series Game 3 Jay-Z Isn't Convinced the ...

Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to weigh on its early-stage drug development clients.

MapLight Therapeutics Inc. shares jumped as much as 23% after the biotechnology firm raised $258.9 million in an initial ...

CONNEQT Health is continuing to strengthen its presence in the US cardiovascular health market after being awarded a new ...

Bahrain Mumtalakat Holding Co. BSC(c), the sovereign wealth fund of the Kingdom of Bahrain, and SandboxAQ, which is focused ...

Dimitri Semenikhin, the retail trader behind the Beyond Meat stock rally is piling into a small biotech that recently pivoted ...

Finding new antibiotics faster could change the face of antimicrobial resistance.

Laramie startups are turning University of Wyoming research into products like natural mouthwash and kidney stone supplements ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or 'Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30 ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

The Swiss pharma is paying $12 billion for Avidity Biosciences and its three late-stage antibody oligonucleotide conjugates.

The University of California, Irvine has licensed a new cancer-fighting immunotherapy to biotech firm GlyTR Therapeutics Inc.